Biotage Ab Stock Analysis

Biotage OTC Stock Analysis Notes

About 65.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 29th of April 2022. Biotage AB provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. Biotage AB was founded in 1969 and is headquartered in Uppsala, Sweden. Biotage Ab is traded on OTC Exchange in the United States.The quote for Biotage AB is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Biotage AB please contact Tomas Blomquist at 46 18 56 59 00 or go to https://www.biotage.com.

Biotage AB Investment Alerts

Biotage Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotage AB's market, we take the total number of its shares issued and multiply it by Biotage AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Biotage Profitablity

The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average.

Technical Drivers

As of the 18th of April 2024, Biotage AB shows the Standard Deviation of 5.0, risk adjusted performance of 0.0863, and Mean Deviation of 1.21. Biotage AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for eleven technical drivers for Biotage AB, which can be compared to its peers. Please confirm Biotage AB variance and maximum drawdown to decide if Biotage AB is priced correctly, providing market reflects its regular price of 16.87 per share. Given that Biotage AB has variance of 24.95, we suggest you to validate Biotage AB's prevailing market performance to make sure the company can sustain itself at a future point.

Biotage AB Price Movement Analysis

Biotage AB Predictive Daily Indicators

Biotage AB Forecast Models

Biotage AB's time-series forecasting models are one of many Biotage AB's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotage AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Biotage AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotage shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Biotage AB. By using and applying Biotage OTC Stock analysis, traders can create a robust methodology for identifying Biotage entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.